Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5256]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg...
GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma ( Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, Germany )
13 Jun 2020
CANDOR updated results: KdD versus Kd in patients with RRMM according to prior...
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg...
CANDOR updated results: KdD versus Kd in patients with RRMM according to prior lines of therapy ( Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, Germany )
13 Jun 2020
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma
Dr Katie Kelley - University of California San Francisco, San Francisco, USA
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )
12 Jun 2020
COVID-19 and breast cancer: How should we treat our patients?
Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain
COVID-19 and breast cancer: How should we treat our patients? ( Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain )
12 Jun 2020
Updated results from KEYNOTE-426 for metastatic kidney cancer
Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA
Updated results from KEYNOTE-426 for metastatic kidney cancer ( Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA )
12 Jun 2020
Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung...
Dr Julia Rotow - Dana Farber Cancer Institute, Boston, USA
Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer ( Dr Julia Rotow - Dana Farber Cancer Institute, Boston, USA )
12 Jun 2020
METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer
Prof Mark Awad - Dana Farber Cancer Institute, Boston, USA
METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer ( Prof Mark Awad - Dana Farber Cancer Institute, Boston, USA )
12 Jun 2020
PARP inhibitors in prostate cancer: Choices of tests and how to test?
Dr Kim Chi and Dr Alexander Wyatt
PARP inhibitors in prostate cancer: Choices of tests and how to test? ( Dr Kim Chi and Dr Alexander Wyatt )
11 Jun 2020
ASCO 2020: Breast cancer roundup
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
ASCO 2020: Breast cancer roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
11 Jun 2020
The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients...
Dr Sara Lonardi - Istituto Oncologico Veneto, Padua, Italy
The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients with RAS-BRAF WT metastatic colorectal cancer ( Dr Sara Lonardi - Istituto Oncologico Veneto, Padua, Italy )
11 Jun 2020
Comparing pevonedistat plus azacitidine versus azacitidine alone in patients...
Prof Lionel Ades - Hôpital Saint-Louis, Paris, France
Comparing pevonedistat plus azacitidine versus azacitidine alone in patients with higher-risk MDS/CMML or low-blast AML ( Prof Lionel Ades - Hôpital Saint-Louis, Paris, France )
11 Jun 2020
ASCO 2020 prostate cancer highlights
Prof Karim Fizazi, Prof Axel Merseburger, Dr Kim Chi and Prof Amit Bahl
ASCO 2020 prostate cancer highlights ( Prof Karim Fizazi, Prof Axel Merseburger, Dr Kim Chi and Prof Amit Bahl )
10 Jun 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation